Cresset Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-6,801
Closed -$237K 955
2020
Q4
$237K Sell
6,801
-18,346
-73% -$651K ﹤0.01% 638
2020
Q3
$916K Sell
25,147
-14,211
-36% -$528K 0.02% 248
2020
Q2
$1.48M Sell
39,358
-11,267
-22% -$451K 0.03% 176
2020
Q1
$1.86M Sell
50,625
-15,290
-23% -$594K 0.06% 124
2019
Q4
$2.67M Sell
65,915
-28,060
-30% -$1.05M 0.07% 113
2019
Q3
$3.26M Sell
93,975
-61,163
-39% -$2.01M 0.1% 96
2019
Q2
$4.92M Buy
155,138
+39,721
+34% +$1.18M 0.15% 74
2019
Q1
$3K Buy
+115,417
New +$3.31M ﹤0.01% 1535

Other funds holding PBH

Cresset Asset Management's PBH Position: Q1 2021 in Review

Cresset Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2021, closing a stake of 6,801 shares — an estimated $237K sold.

Cresset Asset Management first reported a position in PBH in Q1 2019 and held it in 8 quarters. The position peaked at $4.92M in Q2 2019. 241 funds tracked by Wall St. Rank hold PBH as of Q1 2021.

  • Cresset Asset Management reported no remaining Prestige Consumer Healthcare position as of Q1 2021 after selling out during the quarter.
  • Cresset Asset Management sold 6,801 Prestige Consumer Healthcare shares in Q1 2021, an estimated $237K.
  • Cresset Asset Management first reported a position in Prestige Consumer Healthcare in Q1 2019 and held it in 8 quarters.
  • Cresset Asset Management's Prestige Consumer Healthcare position peaked at $4.92M in Q2 2019.
  • 241 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2021.

Based on Cresset Asset Management's 13F filing for Q1 2021, filed 12 May 2021.